RI Research Instruments, a majority-owned subsidiary of Bruker Advanced
Supercon, Inc., today announced the award of an approximately $6 million
contract from the U.S. Department of Energy’s (DOE) Thomas
Jefferson National Accelerator Facility in Newport News, Virginia,
for the production of 86 superconducting accelerating cavities.
The Jefferson Lab contract covers all 86 superconducting cavities for
the 12 GeV (12 billion electron volt) upgrade of the Continuous Electron
Beam Accelerator Facility (CEBAF), for which $65
million of ARRA funding was recently allocated. The 12 GeV upgrade
will secure Jefferson Lab’s leading global position in nuclear and
particle physics research.
These superconducting cavities represent the core components of the
accelerating modules that will be assembled at Jefferson Lab. The use of
superconducting high purity Niobium enables the design of resonant
radio-frequency accelerator cavities with extremely high quality factors
(Q), operating at very high electromagnetic fields at high or 100% duty
cycles. Such electromagnetic fields at high duty cycles would
immediately melt normal-conducting copper cavities. Delivery is
scheduled for the years 2010 and 2011.
Dr. Michael Peiniger, Managing Director of RI Research Instruments,
explained: “This award fits perfectly with our advanced superconductor
manufacturing, electron beam welding and surface treatment technologies.
It is the continuation of a series of production contracts for
accelerating cavities, such as the 360 cavities for the original
installation of CEBAF, all normal conducting (48 units) and
superconducting (106 units) cavities for the Spallation Neutron Source
(Oak Ridge, TN), and over 100 ILC- and XFEL-type superconducting
cavities for DESY (Germany), BESSY (Germany), FNAL (Batavia, IL), etc.
We are committed to serving our global research customers with complete
accelerator systems, as well as with series production services of
sophisticated accelerator subunits.”
-
For more information on Thomas Jefferson National Accelerator
Facility, please visit: www.jlab.org
-
For Jefferson Lab’s Press Release on the 2009 Recovery Act (ARRA)
Funding, please visit www.jlab.org/news/releases/2009/recovery_act_funding.html
About RI Research Instruments and Bruker Advanced Supercon, Inc.:
RI Research Instruments GmbH is a world leader in the development and
manufacturing of rf cavities and systems, linear accelerators, as well
as special products for physics and energy research, scientific, medical
and industrial applications. RI products include electron and ion
sources, LINACs, superconducting and normal conducting accelerator
cavities, other accelerator components, neutron source subunits,
particle beam lines, as well as vacuum and cryogenic systems. RI
Research Instruments was formed as a result of Bruker Advanced
Supercon’s April 1, 2009 acquisition of the research instruments
business of ACCEL Instruments GmbH from Varian Medical Systems. Bruker
has acquired a majority stake in RI Research Instruments and has
retained Dr. Michael Peiniger as Managing Director and the former ACCEL
management team as minority (45%) shareholders in the newly formed
company. Bruker Advanced Supercon, Inc. of Billerica, MA has operations
in the US, the UK and Germany, and is a wholly-owned subsidiary of
Bruker Corporation (NASDAQ: BRKR).
For more information on RI Research Instruments, please visit: www.research-instruments.de
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6003808〈en
RI Research Instruments
Dr. Michael Peiniger, +49 2204 843676
Managing
Director
michael.peiniger@research-instruments.de
